Jana Care Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 55

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $869K

  • Investors
  • 11

Jana Care General Information

Description

Developer of a mobile diagnostic platform designed for diabetes diagnosis and treatment. The company offers smartphone-based diagnostics that check and assess blood levels and deliver personalized care plans for patients, thereby helping users in detecting type 2 diabetes at a fraction of current costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
  • 8 Saint Mary's Street
  • Suite 936
  • Boston, MA 02215
  • United States
+1 (857) 000-0000

Jana Care Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jana Care Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 19-Nov-2021 $869K 000.00 Completed Generating Revenue
5. Debt - General 27-Oct-2020 00000 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 15-Feb-2019 000.00 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Oct-2018 00000 Completed Generating Revenue
2. Angel (individual) 01-Jun-2013 $500K $500K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2011 Completed Generating Revenue
To view Jana Care’s complete valuation and funding history, request access »

Jana Care Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Jana Care’s complete cap table history, request access »

Jana Care Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a mobile diagnostic platform designed for diabetes diagnosis and treatment. The company offers smartphone-b
Monitoring Equipment
Boston, MA
55 As of 2022
000.00
0000000000 0 000.00

00000

ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000000000 000000000
Bengaluru, India
000 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00

0000 0

prehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000 000000000
Woodbridge Township, NJ
00 As of 0000
000.00
000000000. 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jana Care Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Forus Health Venture Capital-Backed Bengaluru, India 000 000.00 0000000000 0 000.00
0000 000000000000 Corporation Woodbridge Township, NJ 00 000.00 000000000. 0 000.00
0000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
00000000000 Formerly VC-backed New York, NY 000 00000 000000000 00000
0000 0000 Private Equity-Backed New York, NY 000 000000000000 000
You’re viewing 5 of 21 competitors. Get the full list »

Jana Care Patents

Jana Care Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210285972-A1 Devices, systems, and methods for measuring biomarkers in biological fluids Pending 13-Mar-2020 000000000
US-20190187154-A1 Biomedical measuring devices, systems, and methods for measuring peptide concentration to monitor a condition Pending 15-Dec-2017 00000000000 0
EP-3724659-A4 Biomedical measuring devices, systems, and methods for measuring peptide concentration to monitor a condition Pending 15-Dec-2017 000000000 0
EP-3724659-A1 Biomedical measuring devices, systems, and methods for measuring peptide concentration to monitor a condition Pending 15-Dec-2017 000000000
JP-2021509709-A Biomedical measuring devices, systems, and methods for measuring peptide concentrations to monitor pathology Pending 15-Dec-2017 G01N33/49
To view Jana Care’s complete patent history, request access »

Jana Care Executive Team (12)

Name Title Board Seat Contact Info
Rajen Dalal Co-Chief Executive Officer & Chairman
Anh Hoang-Lindsay Co-Chief Executive Officer & Board Member
Sridhar Ramanathan Ph.D Chief Operating Officer & Head Bangalore
John Hurrell Ph.D Chief Commercial Officer
Sidhant Jena Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

Jana Care Board Members (12)

Name Representing Role Since
Anh Hoang-Lindsay Jana Care Co-Chief Executive Officer & Board Member 000 0000
Arda Minocherhomjee Ph.D HealthXCapital Board Member 000 0000
Chester Woolley Jana Care Board Member 000 0000
Geoffrey Woolley Patamar Capital Board Member 000 0000
Jean-Luc Butel Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Jana Care Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jana Care Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Grand Challenges Canada Limited Partner Minority 000 0000 000000 0
HealthXCapital Venture Capital Minority 000 0000 000000 0
ImpactAssets Impact Investing Minority 000 0000 000000 0
Innova Capital Partners PE/Buyout Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »